Stock listing
OTC:BETRF BetterLife Pharma Inc. Stock
US listing (OTC) of BetterLife Pharma Inc. · home listing CSE:BETR
Follow BetterLife Pharma Inc. into a list and get an email when it puts out news.
Share price · OTC:BETRF
$0.16 USD -0.01 (-5.9%)
Close on Oct 27, 2026
- Day range
- $0.16 – $0.16 USDOct 27, 2026
- Volume
- 1,000 sharesOct 27, 2026
- Market cap
- $98.88M USDAt the close on Oct 27, 2026 · price × 618.0M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| CSE:BETR · Home | $0.25 CAD | 0.00 (0.0%) | 750,847 | $0.26 | $0.26 | $0.245 | $0.25 | Close on Oct 30, 2026 |
| OTC:BETRF | $0.16 USD | -0.01 (-5.9%) | 1,000 | $0.16 | $0.16 | $0.16 | $0.17 | Close on Oct 27, 2026 |
- Ticker
- OTC:BETRF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
BetterLife Pharma Appoints LifeSci Advisors as Investor Relations Firm
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 18 slides
Latest news
Financings
Public offering of common shares and pre-funded warrants
Sep 17, 2026
Closed: US$100M raised · C$0.25 a share · Bloom Burton Securities Inc. +1
Dealers: Bloom Burton Securities Inc. (lead), Haywood Securities Inc.
Buyers: Deep Track Capital (led the financing); Coastlands Capital (significant co-investment); Marshall Wace (significant co-investment); RA Capital Management (significant co-investment); Perceptive Advisors (significant co-investment); Adage Capital Management (participation); Affinity Asset Advisors (participation); Kalehua Capital (participation); Sphera Fund Management (participation); Squadron Capital Management (participation); Stonepine Capital Management (participation); Woodline Partners LP (participation)
Use of proceeds: Phase 1A, Phase 1B and Phase 2 clinical trials of BETR-001 in cluster headache and migraine, plus working capital and general corporate purposes
Announced Aug 24, 2026 · Terms changed Aug 28, 2026 · Closed Sep 17, 2026
Decks
Investor Presentation (July 2026)
Investor deck · 18 slides · July 2026
Investor Presentation (January 2023)
Investor deck · 15 slides · Jan 13, 2023
Investor Presentation (August 2022)
Investor deck · 15 slides · August 2022
Investor Presentation (December 2021)
Investor deck · 23 slides · December 2021
BetterLife Pharma Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 70 in the last 12 months · 161 in all · newest Oct 27, 2026 · oldest 2011
- Decks
- 5 decks · latest July 2026
Where BetterLife Pharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| CSE:BETR · Home listing | CSE | Canada | CAD |
| OTC:BETRF · This page | OTC | United States | USD |
| Cboe Canada:BETR | Cboe Canada | Canada | CAD |
| Frankfurt:NPAU | Frankfurt | Germany | EUR |
| LS Exchange:A2P7XN | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2P7XN | Lang & Schwarz | Germany | EUR |
| gettex:NPAU | gettex | Germany | EUR |
| Stuttgart:NPAU | Stuttgart | Germany | EUR |
| Munich:NPAU | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about BetterLife Pharma Inc.